References
-
Strelau, J., Bottner, M., Lingor, P., Suter-Crazzolara, C., Galter, D., Jaszai, J., Sullivan, A., Schober, A., Krieglstein, K. and Unsicker, K. (2000) GDF-15/MIC-1 a novel member of the TGF-
$\beta$ superfamily. J. Neural. Transm. Suppl. 60, 273-276 -
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., Walsh, B. J., Nicholson, R. C., Fairlie, W. D., Por, S. B., Robbins, J. M. and Breit, S. N. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-
$\beta$ superfamily. Proc. Natl. Acad. Sci. U.S.A. 94, 11514-11519 https://doi.org/10.1073/pnas.94.21.11514 - Bauskin, A. R., Brown, D. A., Kuffner, T., Johnen, H., Luo, X. W., Hunter, M. and Breit, S. N. (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res. 66, 4983-4986 https://doi.org/10.1158/0008-5472.CAN-05-4067
-
Paralkar, V. M., Vail, A. L., Grasser, W. A., Brown, T. A., Xu, H., Vukicevic, S., Ke, H. Z., Qi, H., Owen, T. A. and Thompson, D. D. (1998) Cloning and characterization of a novel member of the transforming growth factor-
$\beta$ /bone morphogenetic protein family. J. Biol. Chem. 273, 13760- 13767 https://doi.org/10.1074/jbc.273.22.13760 - Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y. and Lu, L. (1997) PLAB, a novel placental bone morphogenetic protein. Biochim. Biophys. Acta. 1354, 40-44 https://doi.org/10.1016/S0167-4781(97)00122-X
-
Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D., Niessen, H. W., Drexler, H. and Wollert, K. C. (2006) The transforming growth factor-
$\beta$ superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ. Res. 98, 351-360 https://doi.org/10.1161/01.RES.0000202805.73038.48 - Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F. Jr. and Hampton, G. M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978
- Buckhaults, P., Rago, C., St. Croix, B., Romans, K. E., Saha, S., Zhang, L., Vogelstein, B. and Kinzler, K. W. (2001) Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61, 6996-7001
- Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., Sutherland, R. L., Breit, S. N., Moskaluk, C. A., Frierson, H. F. and Hampton, G. M. (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. U.S.A. 100, 3410-3415 https://doi.org/10.1073/pnas.0530278100
- Brown, D. A., Ward, R. L., Buckhaults, P., Liu, T., Romans, K. E., Hawkins, N. J., Bauskin, A. R., Kinzler, K. W., Vogelstein, B. and Breit, S. N. (2003) MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin. Cancer Res. 9, 2642- 2650
- Koopmann, J., Buckhaults, P., Brown, D. A., Zahurak, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J,, Hruban, R. H., Breit, S. N., Kinzler, K. W., Vogelstein, B. and Goggins, M. (2004) Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin. Cancer Res. 10, 2386-2392 https://doi.org/10.1158/1078-0432.CCR-03-0165
-
Li, P. X., Wong, J., Ayed, A,. Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C. and Klamut, H. J. (2000) Placental transforming growth factor-
$\beta$ is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem. 75, 20127-20135 -
Tan, M., Wang, Y., Guan, K. and Sun, Y. (2000) PTGF-
$\beta$ , a type$\beta$ transforming growth factor (TGF-$\beta$ ) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-$\beta$ signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 97, 109-114 https://doi.org/10.1073/pnas.97.1.109 -
Graichen, R., Liu, D., Sun, Y., Lee, K. O. and Lobie, P. E. (2002) Autocrine human growth hormone inhibits placental transforming growth factor-
$\beta$ gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells. J. Biol. Chem. 277, 26662-26672 https://doi.org/10.1074/jbc.M109931200 - Albertoni, M., Shaw, P. H., Nozaki, M., Godard, S., Tenan, M., Hamou, M. F., Fairlie, D. W., Breit, S. N., Paralkar, V. M., de Tribolet, N., Van Meir, E. G. and Hegi, M. E. (2002) Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21, 4212-4219 https://doi.org/10.1038/sj.onc.1205610
- Lee, D. H., Yang, Y., Lee, S. J., Kim, K. Y., Koo, T. H., Shin, S. M., Song, K. S., Lee, Y. H., Kim, Y. J., Lee, J. J., Choi, I. and Lee, J. H. (2003) Macrophage inhibitory cytokine- 1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res. 63, 4648-4655
- Kim, K. K., Lee, J. J., Yang, Y., You, K. H., and Lee, J. H. (2008) Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 19, 704-712
- Boyle, G. M., Pedley, J., Martyn, A. C., Banducci, K. J., Strutton, G. M, Brown , D. A., Breit, S. N. and Parsons, P. G. (2009) Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity. J. Invest. Dermatol. 129, 383-391 https://doi.org/10.1038/jid.2008.270
-
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., Hunter, M., Fairlie, W. D., Lee, N. J., Enriquez, R. F., Baldock, P. A., Corey, E., Apple ,F. S, Murakami, M. M, Lin, E. J., Wang, C., During, M. J., Sainsbury, A., Herzog, H. and Breit, S. N. (2007) Tumor-induced anorexia and weight loss are mediated by the TGF-
$\beta$ superfamily cytokine MIC-1. Nat. Med. 13, 1333-1340 https://doi.org/10.1038/nm1677 - Olayioye, M. A., Neve, R. M., Lane, H. A. and Hynes, N. E. (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19, 3159-3167 https://doi.org/10.1093/emboj/19.13.3159
- Yarden, Y. and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2, 127-137 https://doi.org/10.1038/35052073
- Zwick, E., Hackel, P. O., Prenzel, N. and Ullrich, A. (1999) The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol. Sci. 20, 408-412 https://doi.org/10.1016/S0165-6147(99)01373-5
- Argast, G. M., Campbell, J. S., Brooling, J. T. and Fausto, N. (2004) Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem. 279, 34530-34536 https://doi.org/10.1074/jbc.M405703200
- Qiu, Y., Ravi, L. and Kung, H. J. (1998) Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393, 83-85 https://doi.org/10.1038/30012
- Cabioglu, N., Summy, J., Miller, C., Parikh, N. U., Sahin, A. A., Tuzlali, S., Pumiglia, K., Gallick, G. E., and Price, J. E. (2005) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res. 65, 6493-6497 https://doi.org/10.1158/0008-5472.CAN-04-1303
- Fischer, O. M., Hart, S., Gschwind, A. and Ullrich, A. (2003) EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31, 1203-1208 https://doi.org/10.1042/BST0311203
- Tice, D. A., Biscardi, J. S., Nickles, A. L., and Parsons, S. J. (1999) Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 96, 1415-1420 https://doi.org/10.1073/pnas.96.4.1415
- Ishizawar, R. C., Miyake, T. and Parsons, S. J. (2007) c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 26, 3503-3510 https://doi.org/10.1038/sj.onc.1210138
- Xu, W., Yuan, X., Beebe, K., Xiang, Z. and Neckers, L. (2007) Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity. Mol. Cell. Biol. 27, 220-228 https://doi.org/10.1128/MCB.00899-06
- Biscardi, J. S., Maa, M. C., Tice, D. A., Cox, M. E., Leu, T. H. and Parsons, S. J. (1999) c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335-8343 https://doi.org/10.1074/jbc.274.12.8335
- Mook, O. R., Frederiks, W. M. and Van Noorden, C. J. (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta. 1705, 69-89
- Wu, Z. S., Wu, Q., Yang, J. H., Wang, H. Q., Ding, X. D., Yang, F. and Xu, X. C. (2008) Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int. J. Cancer. 122, 2050-2056 https://doi.org/10.1002/ijc.23337
- Kim, S., Choi, J. H., Lim, H. I., Lee, S. K., Kim, W. W., Cho, S., Kim, J. S., Kim, J. H., Choe, J. H., Nam, S. J., Lee, J. E. and Yang, J. H. (2009) EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell Signal 21, 892-898 https://doi.org/10.1016/j.cellsig.2009.01.034
-
Yao, J., Xiong, S., Klos, K., Nguyen, N., Grijalva, R., Li, P., and Yu, D. (2001) Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-
$\beta$ 1 in human breast cancer cells. Oncogene 20, 8066-8074 https://doi.org/10.1038/sj.onc.1204944 - Cho, H. J. and Nam, K. S. (2007) Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP- and cGMPdependent manner by activated MMP-9. J. Biochem. Mol. Biol. 40, 678-683 https://doi.org/10.5483/BMBRep.2007.40.5.678
Cited by
- HER2 induces expression of leptin in human breast epithelial cells vol.45, pp.12, 2012, https://doi.org/10.5483/BMBRep.2012.45.12.164
- Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role? vol.2, pp.12, 2013, https://doi.org/10.5966/sctm.2013-0055
- Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer vol.2012, 2012, https://doi.org/10.5402/2012/428062
- Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland vol.134, pp.2, 2012, https://doi.org/10.1007/s10549-012-2104-7
- Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845 vol.14, pp.6, 2013, https://doi.org/10.3390/ijms140610761
- Diagnostic Performance of Serum Macrophage Inhibitory Cytokine-1 in Pancreatic Cancer: A Meta-Analysis and Meta-Regression Analysis vol.33, pp.6, 2014, https://doi.org/10.1089/dna.2013.2237
- Growth Differentiation Factor-15 (GDF-15) is a potential marker of radiation response and radiation sensitivity vol.793, 2015, https://doi.org/10.1016/j.mrgentox.2015.06.009
- Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside vol.16, pp.6, 2011, https://doi.org/10.3109/1354750X.2011.580006
- Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells vol.82, pp.9, 2011, https://doi.org/10.1016/j.bcp.2011.07.082
- Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231 vol.55, pp.2, 2016, https://doi.org/10.1002/mc.22267
- The oncoprotein ErbB3 is endocytosed in the absence of added ligand in a clathrin-dependent manner vol.33, pp.5, 2012, https://doi.org/10.1093/carcin/bgs128
- The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer vol.85, pp.5, 2013, https://doi.org/10.1016/j.bcp.2012.11.025
- The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1 vol.24, pp.4, 2013, https://doi.org/10.1016/j.cytogfr.2013.05.003
- The value of macrophage inhibitory cytokine-1 level in differentiating benign from malignant solitary pulmonary nodules 2018, https://doi.org/10.1111/crj.12693
- Quantitative label-free proteomic analysis of human urine to identify novel candidate protein biomarkers for schistosomiasis vol.11, pp.11, 2017, https://doi.org/10.1371/journal.pntd.0006045
- Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer vol.37, pp.29, 2018, https://doi.org/10.1038/s41388-018-0243-y